CCL2 regulates angiogenesis via activation of Ets-1 transcription factor

Journal of Immunology

Volumn 177, Issue 4, 2006, Pages 2651-2661

  Stamatovic, Svetlana M ^a   Keep, Richard F ^a   Mostarica Stojkovic, Marija ^b   Andjelkovic, Anuska V ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOGENIC FACTOR; ANTISENSE OLIGONUCLEOTIDE; BETA CHEMOKINE; BETA3 INTEGRIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR ETS 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CONTROLLED STUDY; DNA MICROARRAY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HEMANGIOMA; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN SYNTHESIS REGULATION; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; UPREGULATION;

EID: 33746867542     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.4.2651     Document Type: Article

References (54)

1. Flamme, I., T. Frolich, and W. Risau. 1997. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J. Cell Physiol. 173: 206-210.
2. Jaffe, R. B. 2000. Importance of angiogenesis in reproductive physiology. Semin. Perinatol. 24: 79-81.
3. Tonnesen, M. G., X. Feng, and R. A. Clark. 2000. Angiogenesis in wound healing. J. Invest. Dermatol. 5: 40-44.
4. Koch, A. E. 2003. Angiogenesis as a target in rheumatoid arthritis. Ann. Rheum. Dis. 62: 1160-114.
5. Folkman, J. 2002. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 29: 15-14.
6. Risau, W. 1997. Mechanisms of angiogenesis. Nature 386: 671-674.
7. Distler, J. H., A. Hirth, M. Kurowska-Stolarska, R. E. Gay, S. Gay, and O. Distler. 2003. Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q. J. Nucl. Med. 47: 149-161.
8. Lee, C. H., and P. C. Smits. 2002. Vascular growth factors for coronary angiogenesis. J. Interv. Cardiol. 15: 511-518.
9. Sellke, F. W., R. J. Laham, E. R. Edelman, J. D. Pearlman, and M. Simons. 1998. Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results. Ann. Thorac. Surg. 65: 1540-1544.
10. Koblizek, T. I., C. Weiss, G. D. Yancopoulos, U. Deutsch, and W. Risau. 1998. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr. Biol. 8: 529-524.
11. Kim, S. J., H. Uehara, T. Karashima, M. McCarty, N. Shih, and I. J. Fidler. 2001. Expression of interleukin-8 correlates with angiogenesis, tumorigcnicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice. Neoplasia 3: 33-42.
12. Cao, Y., C. Chen, J. A. Weatherbee, M. Tsang, and J. Folkman. 1995. Gro-β, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice. J. Exp. Med. 182: 2069-2077.
13. Belperio, J. A., M. P. Keane, D. A. Arenberg, C. L. Addison, J. E. Ehlert, M. D. Burdick, and R. M. Strieter. 2000. CXC chemokines in angiogenesis. J. Leukocyte Biol. 68: 1-4.
14. Bernardini, G., D. Ribatti, G. Spinetti, L. Morbidelli, M. Ziche, A. Santoni, M. C. Capogrossi, and M. Napolitano. 2003. Analysis of the role of chemokines in angiogenesis. J. Immunol. Methods 273: 83-101.
15. Isik, F. F., R. P. Rand, J. S. Gruss, D. Benjamin, and C. E. Alpers. 1996. Monocyte chemoattractant protein-1 mRNA expression in hemangiomas and vascular malformations. J. Surg. Res. 61: 71-76.
16. Goede, V., L. Brogelli, M. Ziehe, and H. G. Augustin. 1999. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int. J. Cancer 82: 765-770.
17. Salcedo, R., M. L. Ponce, H. A. Young, K. Wasserman, J. M. Ward. H. K. Keinman, J. J. Oppenheim, and W. J. Murphy. 2000. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 96: 34-40.
18. Leung, S. Y., M. P. Wong, L. P. Chung, A. S. Chan, and S. T. Yuen. 1997. Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas. Acta Neuropathol. 93: 518-527.
19. Weber, K. S., P. J. Nelson. H. J. Grone, and C. Weber. 1999. Expression of CCR2 by endothelial cells implications for MCP-1 mediated wound injury repair and in vivo inflammatory activation of endothelium. Arterioscler. Thromb. Vasc. Biol. 19: 2085-2093.
20. Andjelkovic, A. V., D. D. Spencer, and J. S. Pachter. 1999. Visualization of chemokine binding sites on human brain microvessels. J. Cell Biol. 145: 403-412.
21. Stamatovic, S. M., R. F. Keep. S. L. Kunkel, and A.V. Andjelkovic. 2003. Potential role of MCP-1 in endothelial cell tight junction Opening': signaling via Rho and Rho kinase. J. Cell Sci. 116: 4615-4628.
22. 1 integrins. Am. J. Pathol. 156: 1673-1683.
23. Bach, T. L., C. Barsigian, D. G. Chalupowicz, D. Busler, C. H. Yaen, D. S. Grant, and J. Martinez. 1998. VE-cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels. Exp. Cell Res. 238: 324-334.
24. Oikawa, T., and T. Yamada. 2003. Molecular biology of the Ets family of transcription factors. Gene 303: 11-34.
25. 3. J. Cell. Physiol. 178: 121-132.
26. Sato, Y. 2001. Role of ETS family transcription factors in vascular development and angiogenesis. Cell Struct. Funct. 26: 19-24.
27. Dittmer, J. 2003. The biology of the Ets1 proto-oncogene. Mol. Cancer 2: 29-24.
28. Wernert, N., M. B. Raes, P. Lassalle, M. P. Dehouck, B. Gosselin, B. Vandenbunder, and D. Stehelin. 1992. c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am. J. Pathol. 140: 119-127.
29. -/- mice. Am. J. Pathol. 159: 457-463.
30. Gordillo, G. M., D. Onat, M. Stockinger, S. Roy, M. Atalay, F. M. Beck, and C. K. Sen. 2004. A key angiogenic role of monocyte chemoattractant protein-1 in hemangioendothelioma proliferation. Am. J. Physiol. 287: C866-C873.
31. Gordillo, G. M., M. Atalay, S. Roy, and C. K. Sen. 2002. Hemangioma model for in vivo angiogenesis: inducible oxidative stress and MCP-1 expression in EOMA cells. Methods Enzymol. 352: 422-432.
32. Atalay, M., G. Gordillo, S. Roy, B. Rovin, D. Bagchi, M. Bagchi, and C. K. Sen. 2003. Anti-angiogenic property of edible berry in a model of hemangioma. FEBS Lett. 544: 252-257.
33. Walsh, D. A. 2004. Angiogenesis in osteoarthritis and spondylosis: successful repair with undesirable outcomes. Curr. Opin. Rheumatol. 16: 609-615.
34. Creamer, D., D. Sullivan, R. Bicknell, and J. Barker. 2002. Angiogenesis in psoriasis. Angiagenesis 5: 231-234.
35. Yoshida, S., A. Yoshida, and T. Ishibashi. 2004. Induction of IL-8, MCP-1, and bFGF by TNF-α in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation. Graef. Arch. Clin. Exp. 242: 409-413.
36. Kuroda, T., Y. Kitadai, S. Tanaka, X. Yang, N. Mukaida, M. Yoshihara, and K. Chayama. 2005. Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment. Clin. Cancer Res. 11: 7629-7636.
37. Ueno, T., M. Toi, H. Saji, M. Muta, H. Bando, K. Kuroi, M. Koike, H. Inadera, and K. Matsushima. 2000. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin. Cancer Res. 6: 3282-329.
38. Ohta, M., Y. Kitadai, S. Tanaka, M. Yoshihara, W. Yasui, N. Mukaida, K. Haruma, and K. Chayama. 2003. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas. Int. J. Oncol. 22: 773-778.
39. Fantuzzi, L., P. Borghi, V. Ciolli, G. Pavlakis, F. Belardelli, and S. Gessani. 1999. Loss of CCR2 expression and functional response to monocyte chemotactic protein (MCP-1) during the differentiation of human monocytes: role of secreted MCP-1 in the regulation of the chemotactic response. Blood 94: 875-883.
40. Galvez, B. G., L. Genis, S. Matias-Roman, S. A. Oblander, K. Tryggvason, S. S. Apte, and A. G. Arroyo. 2005. Membrane type 1-matrix metalloproteinase is regulated by chemokines monocyte-chemoattractant protein-1/cc12 and interleukin-8/CXCL8 in endothelial cells during angiogenesis. J. Biol. Chem. 280: 1292-1298.
41. Li, A., S. Dubey, M. L. Varney, B. J. Dave, and R. K. Singh. 2003. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J. Immunol. 170: 3369-3376.
42. Lelievre, E., F. Lionneton, V. Mattot, N. Spruyt, and F. Soncin. 2002. Ets-1 regulates fli-1 expression in endothelial cells: identification of ETS binding sites in the fli-1 gene promoter. J. Biol. Chem. 277: 25143-25151.
43. Westermarck, J., A. Seth, and V. M. Kahari. 1997. Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors. Oncogene 14: 2651-2660.
44. Sato, Y., K. Teruyama, T. Nakano, N. Oda, M. Abe, K. Tanaka, and C. Iwasaka-Yagi. 2001. Role of transcription factors in angiogenesis: Ets-1 promotes angiogenesis as well as endothelial apoptosis. Ann. NY Acad. Sci. 947: 117-123.
45. Hashiya, N., N. Jo, M. Aoki, K. Matsumoto, T. Nakamura, Y. Sato, N. Ogata, T. Ogihara, Y. Kaneda, and R. Morishita. 2004. In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade. Circulation 109: 3035-3041.
46. Zhan, Y., C. Brown, E. Maynard, A. Anshelevich, W. Ni, I. C. Ho, and P. Oettgen. 2005. Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J. Clin. Invest. 115: 2508-2516.
47. Watanabe, D., H. Takagi, K. Suzuma, I. Suzuma, H. Oh, H. Ohashi, S. Kemmochi, A. Uemura, T. Ojima, E. Suganami, et al. 2004. Transcription factor Ets-1 mediates ischemia- and vascular endothelial growth factor-dependent retinal neovascularization. Am. J. Pathol. 164: 1827-1835.
48. Pourtier-Manzanedo, A., C. Vercamer, E. Van Belle, V. Mattot, F. Mouquet, and B. Vandenbunder. 2003. Expression of an Ets-1 dominant-negative mutant perturbs normal and tumor angiogenesis in a mouse ear model. Oncogene 22: 1795-1806.
49. Czuwara-Ladykowska, J., V. I. Sementchenko, D. K. Watson, and M. Trojanowska. 2002. Ets1 is an effector of the transforming growth factor β (TGF-β) signaling pathway and an antagonist of the profibrotic effects of TGF-β J. Biol. Chem. 277: 20399-20408.
50. 3 integrin synergistically rescue angiogenesis via N-Ras and PI3-K signaling in human microvascular endothelial cells. FASEB J. 17: 1931-193.
51. Liu, H., and T. Grundstrom. 2002. Calcium regulation of GM-CSF by calmodulin-dependent kinase II phosphorylation of Ets1. Mol. Biol. Cell 13: 4497-4507.
52. Yang, B. S., C. A. Hauser, G. Henkel, M. S. Colman, C. Van Beveren, K. J. Stacey, D. A. Hume, R. A. Maki, and M. C. Ostrowski. 1996. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol. Cell. Biol. 16: 538-547.
53. Paumelle, R., D. Tulasne, Z. Kherrouche, S. Plaza, C. Leroy, S. Reveneau, B. Vandenbunder, and V. Fafeur. 2002. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway. Oncogene 21: 2309-2319.
54. Seidel, J. J., and B. J. Graves. 2002. An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors. Genes Der. 16: 127-137.